Garcinone A

Garcinone A

Identity and Chemical Characterization

Garcinone A is a naturally occurring prenylated xanthone first isolated and structurally characterized in 1982 by Sen, Sarkar, Mazumder, Banerji, Uusvuori, and Hase. Three new tetraoxygenated xanthones — garcinones A, B, and C — each disubstituted with C5-units, were isolated from the chloroform extract of the fruit hulls of Garcinia mangostana; their structures were established by a combination of spectral interpretation and chemical correlation. The original report was published in the journal Phytochemistry (volume 21, pages 1747–1750, 1982).

The compound is registered in the chemical literature with the International Chemical Identifier (InChIKey) HHHZYUKPVCUMDR-UHFFFAOYSA-N and the ChEBI identifier 175006. The PubChem Compound Identifier (CID) is 70689919, and PubChem records include its structure, chemical names, physical and chemical properties, classification, literature references, and biological activities. The molecular formula is C₂₃H₂₄O₅, corresponding to a molecular weight of approximately 380.44 g/mol.

Xanthones are densely packed with a two-benzene ring structure, and the carbons are numbered from their nucleus and biosynthetic construct. This class of compounds features two benzene rings fused to a pyrone ring; the structural versatility of xanthones is further augmented by the substitution of methoxy, hydroxy, and prenyl groups on the benzene rings. As a tetraoxygenated member of the xanthone series, Garcinone A bears four oxygen-containing substituents on the tricyclic scaffold. The two C5-unit side chains (prenyl-type isoprene-derived units) that distinguish it from simple oxygenated xanthones place it within the broader subclass of prenylated xanthones, the most pharmacologically prominent xanthone subgroup found in the genus Garcinia.

Xanthones have mixed shikimate-acetate (higher plants) and acetate-malonate (lower organisms) biosynthetic origins, which influence their classification; based on the level of oxidation of the C-ring, they are classified into monomers, dimers, and heterodimers, and based on the level of oxygenation or the type of ring residue, they can be categorized into mono-, di-, tri-, tetra-, penta-, and hexa-oxygenated xanthones, bis-xanthones, prenylated and related xanthones, xanthonolignoids, and other miscellaneous xanthones.

This structural diversity has made xanthones exhibit considerable biological properties as promising antioxidant, antifungal, antimicrobial, and anticancer agents; structure-activity relationship studies suggest C-1, C-3, C-6, and C-8 as the key positions that influence the biological activity of xanthones.

Nomenclature and Synonyms

• Preferred IUPAC-type name: Based on the xanthene-9-one scaffold with four hydroxyl/oxy substituents and two C5-prenyl or isoprenyl side chains
• CAS Registry: Listed under PubChem CID 70689919; ChEBI 175006
• Common name: Garcinone A
• Family designation: Prenylated tetraoxygenated xanthone; member of the garcinone series (A, B, C, D, E)

Botanical Source

The primary botanical source of Garcinone A is Garcinia mangostana L. (Clusiaceae), a tropical tree native to Southeast Asia known as mangosteen, whose fruits possess a distinctive and pleasant taste that has granted them the epithet of "queen of the fruits." It is cultivated in the tropical rainforest of Southeast Asian nations such as Indonesia, Malaysia, Sri Lanka, the Philippines, and Thailand.

Prenylated xanthones, dibenzo-γ-pyrone derivatives, are the main compounds present in the fruit, and they possess a plethora of activities in vitro; at least 68 xanthones have been isolated from G. mangostana L. Prenylated xanthones isolated from G. mangostana have been extensively studied; some members of these compounds possess antioxidant, antitumoral, antiallergic, anti-inflammatory, antibacterial, antifungal, and antiviral properties, and xanthones have been isolated from the pericarp, whole fruit, heartwood, and leaves.

Garcinone A was specifically isolated from the fruit hulls (pericarp) of G. mangostana using chloroform extraction, as described in the original 1982 isolation study. The most studied xanthones from this species are α-, β-, and γ-mangostins, garcinone E, 8-deoxygartanin, and gartanin — with garcinone A receiving comparatively less individual pharmacological attention in subsequent decades. Within the garcinone series, the closely related compounds garcinone C, D, and E have been subjected to more extensive biological investigation.

Garcinia plants contain a broad range of biologically active metabolites which, in the last few decades, have received considerable attention due to the chemical compositions of their extracts, with compounds which have been shown to have beneficial effects in several diseases. Many Garcinia species have obtained great prominence for extracts and isolated compounds, such as polyphenols, bioflavonoids, anthocyanins, benzophenones, and xanthones in the treatment of various illnesses.

Traditional and Historical Use

Garcinone A as a defined, isolated chemical entity was not known to traditional medical practitioners; it was first structurally identified in 1982. However, it is a constituent of the fruit hulls of Garcinia mangostana, a plant with a well-documented history of traditional therapeutic use across Southeast Asia and southern China spanning several centuries. The biological actions of the mangosteen pericarp in traditional contexts are therefore attributable to the mixture of xanthones present, including Garcinone A.

Garcinia mangostana Linn., known as mangosteen, is cultivated in the tropical rainforest of Southeast Asian nations like Indonesia, Malaysia, Sri Lanka, the Philippines, and Thailand, where traditional medicine uses the pericarp for the treatment of abdominal pain, diarrhea, cystitis, eczema, dysentery, wound suppuration, and chronic ulcers.

In traditional Thai medicine (TTM), mangosteen pericarps were used to cure inflammation, gonorrhea, leucorrhea, and abdominal pain. The pericarps have been used as folk medicine to treat diarrhea, bladder infections, gonorrhea, and skin rashes for more than one hundred years.

Garcinia mangostana L. (known as Shanzhu in Chinese), commonly known as mangosteen, is a tropical tree traditionally used in Southeast Asia and southern China to treat diarrhea, abdominal pain, skin infections, malaria, and septicemia.

The seeds and pericarps of the fruit have a long history of use in the traditional medicinal practices of the region, and beverages containing mangosteen pulp and pericarps are sold worldwide as nutritional supplements.

Different parts of the plant, like roots, barks, and pericarps, have long been used as herbal medicine in most of the Southeast Asian countries. Traditional preparations ranged from decoctions of the pericarp consumed orally for gastrointestinal complaints to topical applications of the dried rind for wound care, skin infections, and inflammatory dermatological conditions. In traditional medicinal systems, decoctions and infusions prepared from mangosteen fruits have been used to treat skin lesions and various inflammatory conditions.

Chemical Context: Garcinone A within the Xanthone Family

Garcinone A belongs to the "garcinone" series of tetraoxygenated prenylated xanthones, a grouping that includes garcinones A through E. This series is important for understanding the compound's phytochemical context and potential structural basis for biological activity, even where direct studies on Garcinone A specifically are sparse.

The basic skeleton of xanthone is made up of two aromatic rings that fused through a carbonyl group and an oxygen atom; the biological activities of xanthones are associated with their tricyclic scaffold and vary depending on the nature and/or position of their substituent groups. In Garcinone A, the presence of two C5 (isoprenyl/prenyl) side chains and four oxygenated positions on the xanthone core is structurally consistent with the broader prenylated xanthone subclass.

The garcinone A-C series was first distinguished from the better-known mangostins by the nature and positions of their prenyl substituents. Both garcinone C and γ-mangostin structurally differ from garcinone D and α-mangostin, respectively, at C-7; while the latter compounds have a methoxy group, the former ones have a hydroxylation in the same position — and such differences account for the activity displayed. These substitution-pattern differences within the garcinone series illustrate how subtle structural variation can influence pharmacological profile.

The tricyclic framework of xanthones enables them to interact with various biomolecules, eliciting a wide array of biological activities, including antibacterial, anticancer, antioxidant, neuroprotective, and hypoglycemic effects.

Key Constituents and the Xanthone Class Mechanisms of Action

Garcinone A has not been subjected to its own detailed mechanistic pharmacological studies as an isolated compound in the published peer-reviewed literature. However, its structural classification as a prenylated tetraoxygenated xanthone places it within a well-characterized pharmacological class. Mechanisms documented for structurally related prenylated xanthones from Garcinia mangostana are described below, with the understanding that direct mechanistic attribution to Garcinone A specifically cannot be made without dedicated experimental data.

Antioxidant Mechanisms

Prenylated xanthones isolated from G. mangostana have been extensively studied; some members possess antioxidant, antitumoral, antiallergic, anti-inflammatory, antibacterial, antifungal, and antiviral properties. The antioxidant capacity of mangosteen xanthones is generally attributed to the electron-donating capacity of the phenolic hydroxyl groups on the aromatic rings, enabling hydrogen atom or electron transfer to reactive oxygen species.

Anti-inflammatory Mechanisms

In vitro and in vivo laboratory studies have demonstrated that extracts of G. mangostana have very diverse pharmacological activities including anti-inflammatory, cytotoxic, antioxidant, antitumoral, immunomodulatory, neuroprotective, anti-allergic, antibacterial, and antiviral properties. Among the mechanistic pathways investigated for related xanthones, inhibition of nuclear factor kappa-B (NF-κB), cyclooxygenase (COX) enzymes, and inducible nitric oxide synthase (iNOS) have been reported. α-Mangostin, the most extensively studied of the mangosteen xanthones, has been reported to inhibit nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription 3 (STAT3) in animal models and to downregulate mitogen-activated protein kinase (MAPK) and protein kinase B (Akt) signaling pathways.

Anticancer Mechanisms (Class-Level)

Mangosteen pericarp xanthones as a class have been proposed as potential chemopreventive agents for their ability to arrest the cell cycle, suppress tumor cell proliferation, induce apoptosis, and inhibit adhesion, invasion, and metastasis. Xanthones in mangosteen contain several secondary metabolites; xanthones in particular have revealed efficient anticancer activity, and they are a major class of natural polyphenols which contain a xanthene-9-one structural skeleton.

Antimicrobial Mechanisms

The bioactive secondary metabolites of mangosteen are xanthone derivatives that possess potent pharmacological activity. The antimicrobial activity of prenylated xanthones in this species is thought to involve disruption of bacterial membrane integrity and inhibition of cellular metabolic pathways, consistent with the lipophilic prenyl substituents facilitating membrane penetration.

Scientific Evidence by Area of Biological Interest

Important caveat: No dedicated clinical or extensive in vitro/in vivo studies on Garcinone A specifically have been identified in the peer-reviewed literature as of the available sources. The scientific evidence below reflects the state of research on Garcinone A as part of the broader Garcinia mangostana xanthone family and on the garcinone series as a group, with explicit characterization of evidence strength.

Discovery and Structural Science (Level of Evidence: Established Phytochemistry)

Three new tetraoxygenated xanthones (garcinones A, B, and C), each disubstituted with C5-units, were isolated from the chloroform extract of the fruit hulls of Garcinia mangostana; their structures were established by a combination of spectral interpretation and chemical correlation. This primary isolation constitutes the foundational scientific record for Garcinone A's existence as a distinct phytochemical. The structure was further indexed by Wikidata and cross-referenced to PubChem and ChEBI, confirming its chemical identity as a uniquely registered natural product.

Cytotoxic and Anticancer Activity (Garcinone Series; Level of Evidence: Preliminary, In Vitro / Limited In Vivo)

Within the garcinone series, garcinone C, D, and E have been the subjects of dedicated cytotoxicity studies. Bioassay-guided fractionation of an ethanol extract of the pericarps of Garcinia mangostana led to the isolation of known compounds garcinones C and D, gartanin, xanthone I, and γ-mangostin; their structures were elucidated primarily based on MS and NMR data, and the compounds showed significant cytotoxic activities against various human cancer cell lines.

In one study, 24 xanthones were isolated and identified from the pericarps of mangosteen (Garcinia mangostana), and their anti-proliferative activities were tested in ovarian cancer cells; garcinone E was found to exhibit excellent anti-proliferative effects among the tested xanthones, significantly inhibiting the proliferation in HEY, A2780, and A2780/Taxol cells as evidenced by MTT assay, LDH release assay, Hoechst 33342 staining, annexin V/PI staining, and JC-1 staining.

Garcinone E induced endoplasmic reticulum (ER) stress and activated the protective inositol-requiring kinase (IRE)-1α pathway; knocking down IRE-1α further activated the caspase cascade and caused an increase in cell death; moreover, garcinone E eliminated the migratory ability of HEY cells by reducing the expression of RhoA and Rac.

No analogous in vitro anticancer study specifically using isolated Garcinone A has been identified in the accessible peer-reviewed literature. Garcinone A is structurally related to the studied members of the series and is co-occurring in the same botanical source, but independent biological data for Garcinone A cannot be inferred or extrapolated without direct experimental evidence. This represents a significant gap in the literature.

Antimicrobial Activity (Mangosteen Xanthone Class; Level of Evidence: In Vitro, Not Specific to Garcinone A)

Seventeen Thai medicinal plants were investigated for their activity against methicillin-resistant Staphylococcus aureus (MRSA); Garcinia mangostana was identified as the most potent plant, and its activity was traced to the prenylated xanthone α-mangostin (MIC and MBC values of 1.95 and 3.91 µg/ml, respectively). Garcinone A was not identified as the specific active constituent in these antimicrobial studies. The antimicrobial evidence base for the mangosteen plant and its xanthone constituents is derived predominantly from studies on α-mangostin and the mangostins as a group.

Anti-inflammatory Activity (Class-Level; Level of Evidence: In Vitro and Limited Animal Data)

Prenylated xanthones isolated from G. mangostana have been extensively studied; some members of these compounds possess antioxidant, antitumoral, antiallergic, anti-inflammatory, antibacterial, antifungal, and antiviral properties. Studies on individual xanthones from mangosteen, including γ-mangostin and α-mangostin, have shown concentration-dependent reduction in iNOS induction in LPS-activated macrophage cell lines, as well as COX enzyme inhibition.

Antioxidant Activity (Class-Level; Level of Evidence: In Vitro)

Studies have demonstrated that several Garcinia species possess high antioxidant ability, including G. mangostana L., G. indica, G. cambogia, and G. atroviridis; the antioxidant activity of these extracts has been applied to treat various related diseases. The antioxidant assessment of individual xanthones from mangosteen, including compounds co-isolated with Garcinone A, has consistently demonstrated free-radical scavenging properties in cell-free assays. No antioxidant study specifically on isolated Garcinone A has been identified.

Neural and Neuroprotective Activity (Garcinone D as Analogue; Level of Evidence: In Vitro Only)

Garcinone D increased p-STAT3, cyclin D1, Nrf2, and HO-1 levels, and induced cell proliferation in a C17.2 mouse neural stem cell model. This data on garcinone D illustrates that members of the garcinone series can interact with neurological signaling pathways, though this finding has not been replicated for Garcinone A.

Antidiabetic / Enzyme Inhibition (Xanthone Class; Level of Evidence: In Vitro, Computational)

Digestive enzymes such as α-amylase, α-glucosidase, and pancreatic lipase play an important role in the metabolism of carbohydrates and lipids, being attractive therapeutic targets for the treatment of type 2 diabetes and obesity; Garcinia mangostana is an interesting species because xanthones with the potential to inhibit these enzymes have been identified, and the multitarget inhibitory potential of xanthones from G. mangostana against these three enzymes has been assessed. These studies were conducted on other isolated xanthones from the pericarp, not on Garcinone A specifically.

Antiviral Activity (Xanthone Class; Level of Evidence: Computational/In Silico Only)

Research showed 11 compounds with high potential to inhibit ACE2 and 12 compounds to inhibit Mpro; however, only garcinone B possessed a drug-likeness, pharmacokinetic, and toxicity profile that was suitable, and the molecular dynamic study exhibited proper stability interaction between garcinone B with ACE2 and Mpro — making garcinone B, as a xanthone derivative isolate compound, a candidate with promising potential for further study as a COVID-19 treatment as an ACE2 and Mpro inhibitor. Garcinone A was not specifically highlighted in this computational antiviral study.

Body Systems and Health Areas Associated with the Xanthone Class

The broader Garcinia species provide a rich natural source of bioactive compounds with relevant therapeutic properties and anti-inflammatory effects, including treatment of skin disorders, wounds, pain, and infections, having demonstrated antinociceptive, antioxidant, antitumoral, antifungal, anticancer, antihistaminic, antiulcerogenic, antimicrobial, antiviral, vasodilator, hypolipidemic, hepatoprotective, nephroprotective, and cardioprotective properties.

These system-level associations for the Garcinia mangostana xanthone class, as documented in the phytochemical and pharmacological literature, include:

• Immune and inflammatory systems: Modulation of NF-κB, STAT3, COX, and iNOS pathways relevant to both local and systemic inflammation.
• Oncological systems: Cell cycle arrest, apoptosis induction, and inhibition of tumor cell migration and invasion, studied in in vitro models of various human cancers.
• Antimicrobial / Infectious disease: Demonstrated activity against gram-positive bacteria, including antibiotic-resistant strains, antifungal properties, and antiparasitic effects.
• Metabolic systems: Inhibition of digestive enzymes (amylase, glucosidase, lipase) relevant to glycemic and lipid metabolism.
• Neurological systems: Isolated in vitro studies on garcinone D suggest neural stem cell proliferative effects via STAT3/cyclin D1 and Nrf2/HO-1 pathways.
• Dermatological: Traditional topical applications for wound healing, eczema, and skin infections, with some experimental antimicrobial support.

These associations apply to the xanthone class in Garcinia mangostana and cannot be specifically attributed to Garcinone A without dedicated experimental evidence.

Dosage Forms and Dosages Reported in Research

No clinical trials or human pharmacokinetic studies employing isolated Garcinone A have been identified in the peer-reviewed literature. Garcinone A is available as an isolated reference compound from specialist phytochemical suppliers for laboratory use, but it is not established as a standalone dietary supplement ingredient at defined therapeutic dosages.

In the broader Garcinia mangostana xanthone literature, dosages have been reported only for individual related compounds in in vitro cell studies. For example, garcinone E was tested against ovarian cancer cell lines in concentrations used in MTT and LDH assays, exhibiting excellent anti-proliferative effects among 24 tested xanthones, with significant inhibition in HEY, A2780, and A2780/Taxol cells. Garcinone D decreased cell viability of C17.2 cells at high concentrations of 20 and 40 μM, while significantly increasing it at low concentrations of 5 and 10 μM. These cell-culture concentrations are not directly translatable to human doses.

No clinical trials have proven mangosteen fruit to have anticancer effects in humans, and no published studies have proven xanthones to be beneficial to human cells (statement from a US patent document context, noting the state of evidence at that time). This characterization remains broadly accurate for Garcinone A specifically: no human clinical dose data exists.

Evidence Strength Summary

The evidence base for Garcinone A as an individual compound is very limited. The following honest assessment of evidence grades applies:

• Structural identity: Established — confirmed by the original 1982 isolation paper, PubChem, ChEBI, and Wikidata cross-referencing.
• Botanical origin: Established — fruit hull of Garcinia mangostana, chloroform extraction.
• Pharmacological activity specific to Garcinone A: Not established — no dedicated in vitro, in vivo, or clinical studies on isolated Garcinone A have been identified in accessible peer-reviewed literature.
• Class-level biological plausibility: Moderate — based on extensive literature on structurally related mangosteen xanthones (α-mangostin, γ-mangostin, garcinone C, D, E), but direct extrapolation to Garcinone A is scientifically unjustified without compound-specific data.
• Clinical (human) evidence: Absent for Garcinone A specifically and largely absent even for the broader xanthone class.

Safety Considerations

No specific toxicological studies, adverse event reports, or interaction studies focused on isolated Garcinone A have been identified in the accessible peer-reviewed literature. Safety data for the compound must therefore be considered within the context of the broader Garcinia mangostana xanthone literature and general Garcinia research.

A range of biological activities — observed in both in vitro and in vivo models — have been attributed to mangosteen xanthones, including antibacterial, antifungal, antimalarial, anticarcinogenic, and antiatherogenic effects; a study using ethanolic extracts of mangosteen pericarp demonstrated promotion of complete wound healing in MRSA-infected mice and reduction of bacterial load from the first day of treatment.

Concerning related xanthones, one study noted that α-mangostin exhibited the highest antibacterial activity but possessed poor pharmacokinetic properties, rendering it unsuitable for use in an in vivo model due to hepatotoxicity and mutagenicity concerns. These concerns were identified specifically for α-mangostin in that study and have not been directly demonstrated for Garcinone A, but they highlight that the presence of prenylated xanthone structures is not automatically associated with a benign safety profile.

At the species level, adverse event reports associated with Garcinia products include a documented case of possible mania with psychosis linked to Garcinia cambogia use. A possible Garcinia cambogia-induced mania with psychosis was described in a published case report. This is documented for a different species and a different phytochemical class (hydroxycitric acid / benzophenone derivatives) and is not attributable to Garcinone A directly.

The absence of documented adverse events specific to Garcinone A reflects the absence of any human use data as an isolated compound, not a demonstrated safety profile. Given that no human pharmacokinetic, toxicological, or interaction studies exist for Garcinone A as an isolated entity, its safety in humans at any defined dose cannot be characterized from the available literature.

Current Research Status and Future Directions

Within the field of natural product pharmacology, the Garcinia mangostana xanthone family continues to attract research interest. Mangosteen is recognized as one of the most popular tropical fruits and a rich source of oxygenated and prenylated xanthone derivatives; phytochemical investigations continue to yield both new and known prenylated xanthones from the pericarp, with structures established by spectroscopic data analysis including X-ray diffraction, and new compounds tested for cytotoxic activity against cancer cell lines.

Garcinone A, as one of the earliest-characterized members of the garcinone series, has nevertheless not progressed to individual pharmacological profiling in the accessible literature. The compound remains documented primarily as a structural reference and as part of the phytochemical inventory of Garcinia mangostana. Future research specifically characterizing Garcinone A's biological profile — including cytotoxicity, enzyme inhibition, antioxidant activity, and bioavailability — would be required before any evidence-based claims about its health effects could be made.

With their complex molecular framework, diverse substitution modes, and significant pharmacological activity, xanthone compounds have shown great potential in the fields of medicinal chemistry, natural product chemistry, and biomedicine. Garcinone A's structural characteristics place it within a class of growing scientific and pharmaceutical interest, but compound-specific evidence remains a significant unmet need.

References

• PubChem — Garcinone A (CID 70689919): Structure, Chemical Names, Properties, and Biological Activities
• Wikidata — Garcinone A (Q105028299): Chemical Identifiers and Literature References
• Sen, A.K. et al. (1982). The structures of garcinones A, B and C: Three new xanthones from Garcinia mangostana. Phytochemistry, 21, 1747–1750. ScienceDirect (Abstract)
• Yang, S. et al. (2016). Garcinone D, a natural xanthone promotes C17.2 neural stem cell proliferation: Possible involvement of STAT3/Cyclin D1 pathway and Nrf2/HO-1 pathway. Neuroscience Letters. ScienceDirect (Abstract)
• Medicinal Potential of Garcinia Species and Their Compounds. PMC / NCBI (PMC7582350)
• Garcinone-E exhibits anticancer effects in HeLa human cervical carcinoma cells mediated via programmed cell death, cell cycle arrest and suppression of cell migration and invasion. PMC / NCBI (PMC7364682)
• Garcinia mangostana L. Pericarp Extract and Its Active Compound α-Mangostin as Potential Inhibitors of Immune Checkpoint Programmed Death Ligand-1. PMC / NCBI (PMC10574194)
• Garcinone E induces apoptosis and inhibits migration and invasion in ovarian cancer cells. PMC / NCBI (PMC5587559)
• Cytotoxic Prenylated Xanthones from the Pericarps of Garcinia mangostana. PMC / NCBI (PMC6271135)
• Xanthones from the Pericarp of Garcinia mangostana. PMC / NCBI (PMC6154529)
• Potency of Xanthone Derivatives from Garcinia mangostana L. for COVID-19 Treatment through ACE2 and Main Protease Blockade: A Computational Study. PMC / NCBI (PMC10343608)
• Multitarget Action of Xanthones from Garcinia mangostana against α-Amylase, α-Glucosidase and Pancreatic Lipase. PMC / NCBI (PMC9144329)
• Naturally Occurring Xanthones and Their Biological Implications. PMC / NCBI (PMC11396865)
• Potential Role of Garcinol as an Anticancer Agent. PMC / NCBI (PMC3382268)
• Phytochemical, Antimicrobial and Antiprotozoal Evaluation of Garcinia Mangostana Pericarp and α-Mangostin, Its Major Xanthone Derivative. PMC / NCBI (PMC6270423)
• The Potential of α-Mangostin from Garcinia mangostana as an Effective Antimicrobial Agent — A Systematic Review and Meta-Analysis. PMC / NCBI (PMC9219858)
• Two New Chemical Constituents from the Stem Bark of Garcinia mangostana. PMC / NCBI (PMC6271552)
• Antioxidant and Antimicrobial Activities of the Extracts from Different Garcinia Species. PMC / NCBI (PMC8238564)
• Xanthone Dimers in Angiosperms, Fungi, Lichens: Comprehensive Review of Their Sources, Structures, and Pharmacological Properties. PMC / NCBI (PMC11858044)
• Garcixanthone E and Garcimangophenone C: New Metabolites from Garcinia mangostana and Their Cytotoxic and Alpha Amylase Inhibitory Potential. MDPI Life 2022
• Garcinia mangostana — Overview, ScienceDirect Topics
• Evaluation of the Antioxidant, Antidiabetic, and Antiplasmodial Activities of Xanthones Isolated from Garcinia forbesii and Their In Silico Studies. PMC / NCBI (PMC8533219)
• Antimicrobial activity of α-mangostin against Staphylococcus species from companion animals in vitro and therapeutic potential in skin diseases. Frontiers in Cellular and Infection Microbiology 2023
• Antibacterial Activity of Thai Medicinal Plants against Methicillin-resistant Staphylococcus aureus. Fitoterapia (ScienceDirect)
• Toxicological evaluation of Shanzhu Tiqusan, a Garcinia mangostana pericarp-based preparation: Acute and chronic oral safety assessment in rats. Journal of Ethnopharmacology 2025 (ScienceDirect)
• Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential. PMC / NCBI (PMC12652707)